Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-25 Sale | 2024-08-14 4:05 pm | Q32 Bio Inc. | QTTB | TZIANABOS ARTHUR Director | 265 | $24.2 | $6,413 | 7,983 (Direct) | View |
| 2024-01-09 Sale | 2024-02-15 4:33 pm | Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR Director | 13,037 | $0.5711 | $7,445 | 148,498 (Direct) | View |
| 2023-01-09 Sale | 2023-01-11 4:05 pm | Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR Director | 10,616 | $1.3905 | $14,762 | 108,395 (Direct) | View |
| 2022-01-05 Sale | 2022-01-12 4:05 pm | Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR President & CEO | 5,354 | $3.7802 | $20,239 | 114,151 (Direct) | View |
| 2021-02-19 Sale | 2021-02-23 5:28 pm | Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director | 10,000 | $60.67 | $606,652 | 13,447 (Direct) | View |
| 2020-11-23 Sale | 2020-11-25 5:09 pm | Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director | 20,000 | $46.03 | $920,566 | 23,447 (Direct) | View |
| 2020-02-03 Sale | 2020-02-05 4:05 pm | Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR President & CEO | 12,500 | $16.16 | $202,021 | 77,505 (Direct) | View |
| 2020-01-02 Sale | 2020-01-03 5:36 pm | Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR President & CEO | 12,500 | $20.5 | $256,191 | 90,005 (Direct) | View |
| 2019-11-29 Sale | 2019-12-03 4:06 pm | Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR President & CEO | 25,000 | $16.15 | $403,735 | 102,505 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-25 Exercise | 2024-08-14 4:05 pm | N/A N/A | Q32 Bio Inc. | QTTB | TZIANABOS ARTHUR Director | 1,095 | $0 | 7,983 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:19 pm | N/A 2034-06-04 | Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director | 7,639 | $0 | 7,639 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 5:43 pm | N/A 2034-03-24 | Q32 Bio Inc. | QTTB | TZIANABOS ARTHUR Director | 12,767 | $0 | 12,767 (Direct) | View |
| 2024-01-01 Exercise | 2024-02-15 4:33 pm | N/A N/A | Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR Director | 33,420 | $0 | 148,498 (Direct) | View |
| 2024-02-13 Exercise | 2024-02-15 4:17 pm | N/A 2028-12-12 | Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director | 31,739 | $0 | 31,739 (Direct) | View |
| 2024-02-13 Exercise | 2024-02-15 4:17 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director | 31,739 | $2.19 | 31,739 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:26 pm | N/A 2033-06-12 | Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director | 19,441 | $0 | 19,441 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-15 6:14 pm | N/A 2033-06-14 | Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2023-01-01 Exercise | 2023-01-04 4:36 pm | N/A N/A | Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR Director | 33,000 | $0 | 172,151 (Direct) | View |
| 2022-12-01 Disposition | 2022-12-02 4:51 pm | N/A 2030-05-11 | Akouos Inc. | AKUS | TZIANABOS ARTHUR Director | 28,100 | $0 | 0 (Direct) | View |
| 2022-11-30 Equity Swap | 2022-12-02 4:51 pm | N/A N/A | Akouos Inc. | AKUS | TZIANABOS ARTHUR Director | 26,930 | $0 | 0 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 5:04 pm | N/A 2032-06-22 | Akouos Inc. | AKUS | TZIANABOS ARTHUR Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-08 5:00 pm | N/A 2032-06-06 | Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director | 21,000 | $0 | 21,000 (Direct) | View |
| 2022-02-24 Option Award | 2022-02-28 4:05 pm | N/A 2032-02-24 | Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR President & CEO | 408,000 | $0 | 408,000 (Direct) | View |
| 2022-01-01 Exercise | 2022-01-12 4:05 pm | N/A N/A | Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR President & CEO | 13,860 | $0 | 114,151 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-25 5:04 pm | N/A 2031-06-07 | Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director | 11,650 | $0 | 11,650 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-25 4:34 pm | N/A 2031-06-23 | Akouos Inc. | AKUS | TZIANABOS ARTHUR Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2021-02-19 Exercise | 2021-02-23 5:28 pm | N/A 2028-12-12 | Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director | 10,000 | $0 | 13,447 (Direct) | View |
| 2021-02-19 Exercise | 2021-02-23 5:28 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director | 10,000 | $2.19 | 13,447 (Direct) | View |
| 2021-02-05 Option Award | 2021-02-09 4:21 pm | N/A 2031-02-05 | Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR President & CEO | 296,000 | $0 | 296,000 (Direct) | View |
| 2020-11-23 Exercise | 2020-11-25 5:09 pm | N/A 2028-12-12 | Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director | 20,000 | $0 | 23,447 (Direct) | View |
| 2020-11-23 Exercise | 2020-11-25 5:09 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director | 20,000 | $2.19 | 23,447 (Direct) | View |
Ownership | 2020-06-25 7:12 pm | N/A N/A | Akouos Inc. | AKUS | TZIANABOS ARTHUR Director | 0 | $0 | 39,030 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 5:32 pm | N/A 2030-06-02 | Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director | 14,777 | $0 | 14,777 (Direct) | View |
| 2019-12-11 Option Award | 2019-12-13 4:07 pm | N/A 2029-12-11 | Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR President & CEO | 358,000 | $0 | 358,000 (Direct) | View |